Total Funding
77
54
Total FundingPost-IPO Equity raised
Growth Score
-10 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
8500
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
- Harith Rajagopalan: Co-Founder & CEO
Jay Caplan: Co-founder & PresidentPast Role: Candela Corporation, Chief Operating Officer
About the Company
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better
solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.
Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
